Based on these findings, we hypothesize that MSH6/2 and PD-L1 expressions could affect pituitary tumor proliferation, and invasion by pathological classification of NFPAs and ICIs may be effective for NFPA subtypes with decreased MSH6/2 expression and increased PD-L1 expression. This evidence concerns the gene CD274 and non-functioning pituitary adenoma.